← Back to headlines
Goldman Sachs Maintains Buy Rating on Intuitive Surgical
Goldman Sachs has reiterated its 'Buy' rating for Intuitive Surgical (ISRG), indicating continued confidence in the company's stock performance.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
